angiopoietin

(redirected from Ang2)
Also found in: Wikipedia.

angiopoietin

(an″jē-ō-poy-ē′tĭn; -poy′ĕ-tĭn) [ angio- + -poiet(ic) + -in]
Any of several genes (or the proteins they encode) that stimulate new blood vessel formation. The proteins encoded by angiopoietin are found in healthy cardiac endothelium and in diseased tissues such as arthritic joints and malignant tumors.
References in periodicals archive ?
For those patients in the high baseline ANG2 subgroup who received a combination of lenvatinib and everolimus for the treatment of mRCC, an overall survival benefit is shown (HR=0.
DIG-KT binds VEGFR2/KDR and Tie-2 simultaneously, and blocks binding of VEGFR2 ligands, including VEGF-A, VEGF-C and VEGF-D, as well as Tie-2 ligands, including Ang1, Ang2, Ang3 and Ang4.
REGN910 is a fully human monoclonal antibody discovered using Regeneron VelocImmune antibody technology that binds and inhibits Ang2.
Thus, Ang2 is one of the earliest tumor markers described; it is also one of the most general because it marks co-opted vessels and not the tumor cells themselves.
Ang2 is one of the most potent vasopressors in humans and plays an important role in blood pressure regulation (2,3).
Inhibition of HPTP restores Tie2 signaling and overcomes the effect of the natural Tie2 inhibitor, Ang2, restoring vascular stability and, in turn, reducing vascular leak and pathologic angiogenesis.
REGN910-3, a combination product comprised of an antibody to Ang2 co-formulated with EYLEA in a single injection, recently had a Phase 1 study in ophthalmology initiated.
These in vivo data showed silencing of Ang2 in the lung, and contribute to existing data demonstrating the potential for developing RNAi therapeutics that target diseases associated with the lung, such as respiratory syncytial virus (RSV) infection, influenza, and asthma.
The Company's revenues and net income in both the second quarter and first half of 2013 were reduced by two $10 million up-front payments made to Sanofi to acquire full rights to antibodies to PDGF and antibodies to Ang2 in ophthalmology, as described below.
Yancopoulos continued, "We have also recently reported on the cloning of another member of the Angiopoietin family, Ang2, which appears to be a negative regulator of angiogenesis.
5,814,464 covering the gene that encodes human Angiopoietin-2 (Ang2) protein and a method of using the gene to make the Ang2 protein.